ArticleFrontiers in medicine2025
Bronchial artery-pulmonary artery fistula with pulmonary embolism and massive hemoptysis: a rare case report and literature review.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bronchial artery-pulmonary artery fistula is a rare vascular anomaly, either congenital or acquired due to recurrent infections. When associated with pulmonary embolism and massive hemoptysis, it significantly increases the risk of mortality and poses complex therapeutic challenges. Only two such cases have been reported in the literature based on PubMed and CNKI database. Anticoagulation therapy requires careful management to balance thrombotic and hemorrhagic risks. Case presentation: A 60-year-old male who presented with recurrent massive hemoptysis was diagnosed with a bronchial artery-pulmonary artery fistula and pulmonary embolism, confirmed by computed tomography pulmonary angiography and digital subtraction angiography. Hemostasis was achieved through bronchial artery embolization, followed by individualized anticoagulation therapy with warfarin, adjusted according to INR monitoring. Conclusion: This case underscores the importance of a personalized diagnostic and therapeutic approach in managing the coexistence of vascular fistula, pulmonary embolism, and hemoptysis. Bronchial artery embolization remains the cornerstone of acute bleeding control, while a carefully tailored and closely monitored anticoagulation strategy is essential to reduce thrombotic risk without increasing the likelihood of hemorrhagic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.